In preclinical metabolic studies, experimental consistency hinges on compound purity and verified molecular structure. Procuring 5-Amino-1MQ that is third-party tested ensures precise nicotinamide N-methyltransferase (NNMT) inhibition without baseline contamination. PX1 Research delivers fully analytical-grade research compounds verified by independent ISO 17025 accredited laboratories.
In preclinical metabolic studies, experimental consistency hinges on compound purity and verified molecular structure. Procuring 5-Amino-1MQ that is third-party tested ensures precise nicotinamide N-methyltransferase (NNMT) inhibition without baseline contamination. PX1 Research delivers fully analytical-grade research compounds verified by independent ISO 17025 accredited laboratories.
A 5-amino-1mq third party tested sample refers to a batch of 5-amino-1-methylquinolinium chloride that has undergone independent analytical verification by an accredited laboratory unrelated to the manufacturer. This testing utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to establish chemical purity and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass, ensuring the compound is free from synthesis precursors and heavy metal contaminants.
For laboratory investigators evaluating cellular bioenergetics, using unverified reference material introduces substantial confounding variables. Impurities in small-molecule inhibitors can alter enzyme kinetics, induce off-target cytotoxicity in cell cultures, or obscure true physiological responses in rodent models. Independent validation provides lot-specific transparency, allowing researchers to correlate biological outcomes directly with specified concentration thresholds.
PX1 Research enforces strict quality control parameters across every production batch. Each lot of 5-Amino-1MQ undergoes comprehensive third-party testing before release, ensuring that published assay protocols remain reproducible across different phase trials and experimental runs.
5-Amino-1MQ (5-amino-1-methylquinolinium) functions primary as a selective, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT is a cytosolic enzyme responsible for catalyzing the methylation of nicotinamide (NAM) using S-adenosylmethionine (SAM) as the methyl donor, producing N1-methylnicotinamide (MNAM) and S-adenosylhomocysteine (SAH). In metabolic tissues such as white adipose tissue (WAT) and skeletal muscle, elevated NNMT activity depletes cellular pools of NAM and SAM.
By inhibiting NNMT, 5-Amino-1MQ prevents the irreversible clearance of nicotinamide. This conservation allows cell systems to salvage NAM back into the nicotinamide adenine dinucleotide (NAD+) synthetic pathway via nicotinamide phosphoribosyltransferase (NAMPT). Preclinical investigations documented in the PX1 Research Library demonstrate that suppressing NNMT activity restores endogenous NAD+ availability, thereby influencing downstream metabolic cascades.
Furthermore, because NNMT consumes SAM as a methyl donor, excessive NNMT activity alters the SAM/SAH ratio—a crucial driver of histone methylation and epigenetic gene regulation. Inhibiting NNMT with third-party verified 5-Amino-1MQ stabilizes methyl donor availability, offering a dual mechanism for studying both metabolic rate regulation and epigenetic signaling in cell culture models.
In vitro and in vivo studies indicate that NNMT inhibition directly enhances cellular energy expenditure. When intracellular NAD+ concentrations rise following 5-Amino-1MQ administration, NAD+-dependent enzymes—specifically sirtuin-1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP1)—experience increased catalytic capacity. SIRT1 activation promotes the deacetylation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis.
Rodent models of diet-induced obesity treated with selective NNMT inhibitors demonstrated measurable increases in oxygen consumption, enhanced mitochondrial density in skeletal muscle, and elevated basal metabolic rates without alterations in food intake. These findings suggest that 5-Amino-1MQ modulates basal energy homeostasis by shifting cellular metabolism toward oxidative phosphorylation.
Because small variations in inhibitor potency can skew kinetic data in NAD+ salvage assays, researchers require strictly quantitated reference material. Utilizing NNMT inhibitors in metabolic research that have undergone RP-HPLC purity verification guarantees that observed increases in cellular ATP production stem exclusively from targeted NNMT suppression.
Adipose tissue dynamics represent a major focal point for 5-Amino-1MQ investigation. In high-fat diet rodent models, over-expression of NNMT in adipocytes correlates strongly with adipocyte hypertrophy and diminished metabolic flexibility. In vitro assays using 3T3-L1 adipocyte cell lines show that application of 5-Amino-1MQ reduces intracellular lipid accumulation during differentiation.
Preclinical data indicate that inhibiting NNMT shifts white adipocytes toward a phenotype resembling beige adipose tissue—a process characterized by increased expression of uncoupling protein 1 (UCP1). UCP1 uncouples mitochondrial electron transport from ATP synthesis, dissipating energy as heat and accelerating fatty acid oxidation within the lysate.
Researchers analyzing lipolysis, fatty acid transport proteins, or adipokine secretion profiles must control for endotoxin levels in their test articles. Endotoxin contamination can trigger inflammatory signaling through Toll-like receptor 4 (TLR4), confounding studies on adipocyte remodeling. PX1 Research subjects all lot batches to Chromogenic LAL endotoxin testing to ensure clean baseline data in adipose cultures.
To establish absolute chemical identity and purity, PX1 Research utilizes a multi-tiered analytical testing workflow performed by independent USA laboratories. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary quantitative method for determining chemical purity. Through a non-polar stationary phase and a polar mobile phase gradient, RP-HPLC separates the target molecule from synthetic byproducts, resolving purity to percentages exceeding 98.0%.
Electrospray Ionization Mass Spectrometry (ESI-MS) provides definitive molecular weight verification. ESI-MS ionizes the sample and measures the mass-to-charge ratio (m/z) of the parent ion. For 5-Amino-1MQ chloride (C10H11N2+), the mass spectrum must show a prominent monoisotopic peak matching the theoretical ion mass, ruling out positional isomers or structural degradation.
Finally, bacterial endotoxin testing via Limulus Amebocyte Lysate (LAL) assay confirms that the compound meets strict limits for cell culture safety. Excess endotoxins can alter cytokine expression in macrophages and endothelial cells, invalidating cell-based assays. Full certificates detailing HPLC chromatograms, MS spectra, and endotoxin values are available for every lot.
Reading a Certificate of Analysis (COA) requires examining several core parameters to verify batch authenticity. The top section of a compliant COA must list matching lot numbers, manufacturing dates, analytical testing dates, and the name of the third-party testing facility. Researchers should confirm that the testing facility operates under ISO 17025 accreditation to ensure standard compliance.
The HPLC section presents a chromatogram detailing retention time and peak area percentages. The main peak corresponding to 5-Amino-1MQ should account for >98% of the total integrated peak area, with minor secondary peaks remaining below established safety thresholds. The MS section must reflect the expected molecular mass without unexplained high-mass adducts or low-mass cleavage products.
Lastly, physical properties including appearance (crystalline powder), solubility profiles, and moisture content (loss on drying) should be cataloged. Reviewing these metrics prevents the introduction of sub-quality reagents into sensitive enzymatic kinetics assays. PX1 Research posts verified COAs directly accessible for every batch of all research compounds.
When evaluating small molecules and peptides targeted at bioenergetics, researchers often compare 5-Amino-1MQ against other key metabolic regulators. While 5-Amino-1MQ acts upstream via enzyme inhibition to preserve NAD+, mitochondrial peptides like MOTS-c function by translocating to the nucleus during metabolic stress to regulate folate cycle pathways and AMPK phosphorylation. Detailed mechanisms are explored in our MOTS-c research guide.
Another relevant benchmark is SLU-PP-332, a synthetic estrogen-related receptor (ERR) agonist that directly upregulates oxidative muscle fiber gene networks. Unlike 5-Amino-1MQ's primary focus on nicotinamide conservation and SAM preservation, ERR agonists directly induce transcriptional activation of mitochondrial enzymes.
Similarly, AMP-activated protein kinase (AMPK) activators like AICAR bypass upstream NAD+ regulation to stimulate glucose uptake and fatty acid oxidation directly. The table below illustrates structural and functional differences across these metabolic research tools:
5-Amino-1MQ chloride is a synthetic small-molecule salt supplied as a lyophilized powder. Achieving stable solution kinetics in vitro requires proper solvent selection based on assay sensitivity. The compound exhibits high solubility in polar organic solvents such as Dimethyl Sulfoxide (DMSO) and Dimethylformamide (DMF), reaching concentrations up to 20 mg/mL.
For aqueous cell culture media systems, stock solutions prepared in DMSO should be diluted into sterile physiological buffers, such as Phosphate-Buffered Saline (PBS, pH 7.4), ensuring final DMSO concentrations remain below 0.1% (v/v) to avoid vehicle-induced cytotoxicity. Direct aqueous solubility in pure water or saline is moderate but can be enhanced by gentle sonication.
Always prepare stock solutions under aseptic conditions using sterile filters (0.22 µm PTFE or PVDF membranes). Working aliquots should be prepared immediately after solvent addition to minimize freeze-thaw cycles, which can induce gradual hydrolytic degradation over extended experimental timelines.
Maintaining structural integrity over storage periods requires controlling temperature, light, and humidity exposure. Dry lyophilized 5-Amino-1MQ powder remains stable at -20°C for up to 24 months. For long-term archival storage (>2 years), maintaining temperature controls at -80°C under an inert nitrogen atmosphere is recommended to prevent oxidation.
Reconstituted liquid stock solutions in DMSO demonstrate stability at -20°C for up to 3 to 6 months when stored in airtight, amber microcentrifuge tubes to shield against photo-degradation. Avoid repeated freeze-thaw cycles, as moisture condensation can accelerate solute precipitation and compound breakdown.
When handling powder samples, allow the container to equilibrate to ambient room temperature inside a desiccator before opening. This practice prevents ambient atmospheric moisture from condensing onto the cold powder, ensuring accurate gravimetric measurements during micro-balance weighing protocols.
Procuring research compounds from compliant domestic suppliers eliminates risks associated with international customs delays, degraded cold-chain shipments, and unverified chemical purities. PX1 Research operates fully compliant domestic distribution centers shipping directly from California and Arizona, ensuring rapid turnaround times for domestic research laboratories.
Every batch of 5-Amino-1MQ distributed by PX1 Research is synthesized in state-of-the-art facilities utilizing Good Manufacturing Practice (GMP) standards and tested by independent ISO 17025 accredited analytical laboratories. We provide full transparency with batch-specific documentation accessible prior to purchase.
Principal investigators and laboratory procurement officers seeking high-volume reference material for prospective trials can establish institutional accounts through our wholesale lab program. PX1 Research remains committed to advancing open science by delivering verified, analytical-grade reference compounds nationwide.
What testing methods verify 5-Amino-1MQ purity?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for quantitative chemical purity (>98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm molecular identity and exact mass.
What is the biological target of 5-Amino-1MQ in research?
5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide clearance and cellular energy regulation.
How does 5-Amino-1MQ influence intracellular NAD+ levels?
By inhibiting NNMT, 5-Amino-1MQ prevents the methylation of nicotinamide, allowing it to remain available for recycling into NAD+ via the salvage pathway.
What endotoxin limits are enforced for PX1 Research compounds?
PX1 Research subjects batches to Chromogenic LAL testing to ensure endotoxin levels meet strict parameters compatible with sensitive cell culture assays.
How should 5-Amino-1MQ powder be stored upon receipt?
Lyophilized powder should be stored desiccated at -20°C for short-to-medium term storage, or at -80°C for long-term storage, protected from light and moisture.
Which solvents are recommended for reconstituting 5-Amino-1MQ?
DMSO and DMF are the preferred primary solvents for preparing high-concentration stock solutions. Stocks can then be diluted into physiological buffers like PBS for working assays.
Where are PX1 Research compounds manufactured and shipped from?
PX1 Research compounds are manufactured in GMP-compliant facilities and shipped directly from our USA distribution hubs in California and Arizona.
Can institutions purchase bulk quantities of 5-Amino-1MQ?
Yes, verified academic and commercial research laboratories can establish bulk procurement accounts via the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.